Evaluating the cost-effectiveness of pharmacologic therapy: where we've been and where we're going.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000191:economics; D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis / Q000592:standards / Q000639:trends*; D004992:Ethics, Medical; D005069:Evaluation Studies as Topic; D006801:Humans
D000998:Antiviral Agents